Products & Services|
For other years, choose below: |
News - 2010Veriteq, a Vaisala company, Launches Newest
Continuous Monitoring System
July 28 2010 — Veriteq has released the newest version of their continuous monitoring and alarming system: viewLinc 3.5. Fully validatable for FDA regulated and GxP compliant environments, the viewLinc system provides continuous records, 24/7 alarming, and automated reporting. More powerful than ever, viewLinc is easily deployed for monitoring temperature, relative humidity, CO2, differential pressure, level, door switches, and more. Read about the newest viewLinc enhancements... Veriteq, a Vaisala company, Launches New Cleanroom Monitoring SolutionApril 20, 2010 � Vancouver, British Columbia, CANADA Pharmaceutical, biotechnical and critical environment quality managers who maintain absolute cleanroom conditions can now ensure gap-free records for temperature, relative humidity and differential pressure with the viewLinc� 3-in-1 monitoring solution. (www.veriteq.com/cleanroom-monitoring/index.htm) Ken Appel, Marketing Manager of Regulated Markets for Veriteq (now part of the Vaisala Group) says that while the key objective of the viewLinc� cleanroom monitoring solutions is to protect product and meet FDA requirements, what sets viewLinc apart from other cleanroom monitoring systems is the ability to provide a continuous record of gap-free data. "With viewLinc your data are always available � even during network interruptions or power failures,� says Appel. Read more... Vaisala Signs Contract to Acquire Veriteq InstrumentsMarch 29, 2010, Vancouver, British Columbia, CANADA Vaisala strengthens its position in the life science market through the strategic acquisition of Veriteq Instruments Inc., a continuous monitoring system and data logger company based in Canada. Veriteq is a leading provider of productized continuous monitoring systems and data logger solutions for the life science industry comprising of pharmaceutical, biotechnological and medical device companies. Veriteq Instruments Inc., reached 5 MEUR net sales in 2009. The company employs approximately 40 persons and it is located in Vancouver, Canada.The value of the deal is 8.5 MEUR, including a conditional purchase price of 0.7 MEUR. The acquisition is expected to be closed on 31 March 2010. �How to Respond to (and Avoid) FDA Form 483s�February 12, 2010, Vancouver, British Columbia, CANADA Understanding how to deal with Form 483 observations is critical to ensuring optimal quality processes, product efficacy, and patient safety. This new 10-step guide from Veriteq Instruments "How to Respond to (and Avoid) FDA 483s" will help pharmaceutical manufacturing and processing facilities, clinical laboratories, medical device manufacturers, and other GxP compliant facilities respond appropriately to the agency within the new 15-day window. |
|
